StockTipsArenaBeta

BUY Granules India — Vishnu Kant Upadhyay, Master Capital Services

BUYGranules India
Granules India share price target & all analyst calls

byVishnu Kant Upadhyay, Master Capital ServicesHorizon: NA (inferred Swing (≤2wk))29 May 2026via Business Today

Entry₹773.85Inferred
Target₹830
Total upside +7.26% (call closed)
Stop loss₹750-3.08% risk
At expiry₹763.1511 Jun 2026, 3:30 pm
Expired-1.38%
Follow Vishnu Kant Upadhyay for new calls(13% target hit, 103 closed calls)Get alertsWatch GRANULES for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 12:01 am IST
2 supporting0 opposing
Supports the BUY call (2)

Granules India's subsidiary, Granules Pharmaceuticals, Inc. (GPI), received a Voluntary Action Indicated (VAI) classification from the US FDA for its Chantilly facility's Establishment Inspection Repo

BSE · Company Update·3 Jun · 1w ago

(opens in new tab)

Granules Pharmaceuticals, Inc. has received an Establishment Inspection Report (EIR) from the USFDA for its Chantilly facility. This indicates a successful inspection and regulatory compliance.

NSE · Press Release·3 Jun · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Granules India

All analyst calls on Granules India

More from Vishnu Kant Upadhyay, Master Capital Services

Every call and its outcome